Not applicableStudy completedNCT06125314
What this trial is testing
HER2 TREAT Study: Retrospective Study to Estimate the Prevalence of HER2-low in Unresectable and/or Metastatic Breast Cancer Patients Who Progress on Anti-Cancer Therapy Identified as HER2-Negative From Patient Medical Records in The Gulf Cooperation Council
Who this might be right for
Breast NeoplasmsBreast CancerBreast Carcinoma+2 more
AstraZeneca 517